FI913625A0 - Behandling av nedsatt funktion av leukocyter med gm-csf. - Google Patents

Behandling av nedsatt funktion av leukocyter med gm-csf.

Info

Publication number: FI913625A0
Authority: FI; Finland
Prior art keywords: csf; nedsatt; leukocyter; behandling; funktion
Prior art date: 1989-01-30

Application number

FI913625A

Other languages

English (en)

Finnish (fi)

Inventor

Eric M Bonnem

Original Assignee

Schering Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-01-30

Filing date

1991-07-30

Publication date

1991-07-30

1991-07-30 Application filed by Schering Corp filed Critical Schering Corp

1991-07-30 Publication of FI913625A0 publication Critical patent/FI913625A0/fi

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/193—Colony stimulating factors [CSF]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Immunology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Zoology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Diabetes (AREA)
Hematology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
External Artificial Organs (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

FI913625A 1989-01-30 1991-07-30 Behandling av nedsatt funktion av leukocyter med gm-csf. FI913625A0 (fi)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US30439189A	1989-01-30	1989-01-30
PCT/US1990/000379 WO1990008554A1 (en)	1989-01-30	1990-01-26	Treatment of leukocyte dysfunction with gm-csf

Publications (1)

Publication Number	Publication Date
FI913625A0 true FI913625A0 (fi)	1991-07-30

Family

ID=23176323

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI913625A FI913625A0 (fi)	1989-01-30	1991-07-30	Behandling av nedsatt funktion av leukocyter med gm-csf.

Country Status (21)

Country	Link
US (1)	US5178855A (xx)
EP (2)	EP0382381B1 (xx)
JP (1)	JPH0651640B2 (xx)
KR (1)	KR0137361B1 (xx)
AT (1)	ATE89737T1 (xx)
AU (1)	AU633054B2 (xx)
CA (1)	CA2045605C (xx)
DE (1)	DE69001686T2 (xx)
DK (1)	DK0382381T3 (xx)
ES (1)	ES2055314T3 (xx)
FI (1)	FI913625A0 (xx)
HK (1)	HK46196A (xx)
HU (1)	HU207229B (xx)
IE (1)	IE64234B1 (xx)
IL (1)	IL93219A (xx)
MY (1)	MY105798A (xx)
NZ (1)	NZ243953A (xx)
OA (1)	OA09509A (xx)
PT (1)	PT92995B (xx)
WO (1)	WO1990008554A1 (xx)
ZA (1)	ZA90600B (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH05506673A (ja) *	1991-02-22	1993-09-30	アムジエン・インコーポレーテツド	迅速な創傷の治癒を促進するためのｇｍ―ｃｓｆ及びｇ―ｃｓｆの使用
GB9120304D0 (en) *	1991-09-24	1991-11-06	Erba Carlo Spa	Stable pharmaceutical compositions containing a granulocyte macrophage colony stimulating factor
WO1994028919A1 (en) *	1993-06-08	1994-12-22	Ajinomoto Co., Inc.	Hematopoietic cell proliferation accelerator
US5777193A (en) *	1994-03-04	1998-07-07	Ludwig Institute For Cancer Research	Animals with targeted gene disruption
US5942253A (en)	1995-10-12	1999-08-24	Immunex Corporation	Prolonged release of GM-CSF
US20080076706A1 (en)	1997-07-14	2008-03-27	Bolder Biotechnology, Inc.	Derivatives of Growth Hormone and Related Proteins, and Methods of Use Thereof
US7153943B2 (en)	1997-07-14	2006-12-26	Bolder Biotechnology, Inc.	Derivatives of growth hormone and related proteins, and methods of use thereof
US6753165B1 (en) *	1999-01-14	2004-06-22	Bolder Biotechnology, Inc.	Methods for making proteins containing free cysteine residues
US8288126B2 (en)	1999-01-14	2012-10-16	Bolder Biotechnology, Inc.	Methods for making proteins containing free cysteine residues
US6911204B2 (en)	2000-08-11	2005-06-28	Favrille, Inc.	Method and composition for altering a B cell mediated pathology
WO2008079295A1 (en) *	2006-12-22	2008-07-03	Novadel Pharma Inc.	Stable anti-nausea oral spray formulations and methods
US7826202B2 (en) *	2007-08-09	2010-11-02	Haworth, Inc.	Modular electrical distribution system for a building

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5078996A (en) *	1985-08-16	1992-01-07	Immunex Corporation	Activation of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factor
EP0238655A4 (en) *	1985-10-03	1989-09-11	Biogen Nv	POLYPEPTIDES LIKE THE GRANULOCYTE-MACROPHOUS COLONY STIMULATION FACTORS (GM-CSF) AND THEIR METHODS OF PRODUCING LARGE QUANTITIES IN MICROBIAL CELLS.
JPH0618778B2 (ja) *	1985-10-04	1994-03-16	中外製薬株式会社	白血球減少症治療剤
JPH0764742B2 (ja) *	1985-11-27	1995-07-12	ジェネティックス・インスチチュ−ト・インコ−ポレ−テッド	Ａｉｄｓ型疾患治療用組成物
JP2579981B2 (ja) *	1986-05-06	1997-02-12	ジェネティックス・インスチチュート・インコーポレーテッド	Ｍ―ｃｓｆの生産方法
US5162111A (en) *	1986-07-30	1992-11-10	Grabstein Kenneth H	Treatment of bacterial diseases with granulocyte-macrophage colony stimulating factor
EP0276846A3 (en) *	1987-01-29	1989-07-26	Zymogenetics, Inc.	Colony-stimulating factor derivatives
IL88344A (en) *	1987-11-12	1994-06-24	Schering Corp	Accelerating bone formation using a factor that accelerates colonies of granulocyte macrophages

1990
- 1990-01-26 JP JP2503253A patent/JPH0651640B2/ja not_active Expired - Lifetime
- 1990-01-26 DK DK90300840.7T patent/DK0382381T3/da active
- 1990-01-26 ZA ZA90600A patent/ZA90600B/xx unknown
- 1990-01-26 ES ES90300840T patent/ES2055314T3/es not_active Expired - Lifetime
- 1990-01-26 DE DE9090300840T patent/DE69001686T2/de not_active Expired - Fee Related
- 1990-01-26 HU HU901977A patent/HU207229B/hu not_active IP Right Cessation
- 1990-01-26 US US07/721,586 patent/US5178855A/en not_active Expired - Fee Related
- 1990-01-26 AU AU50488/90A patent/AU633054B2/en not_active Ceased
- 1990-01-26 MY MYPI90000141A patent/MY105798A/en unknown
- 1990-01-26 AT AT90300840T patent/ATE89737T1/de not_active IP Right Cessation
- 1990-01-26 WO PCT/US1990/000379 patent/WO1990008554A1/en not_active Application Discontinuation
- 1990-01-26 CA CA002045605A patent/CA2045605C/en not_active Expired - Fee Related
- 1990-01-26 EP EP90300840A patent/EP0382381B1/en not_active Expired - Lifetime
- 1990-01-26 KR KR1019900702160A patent/KR0137361B1/ko not_active IP Right Cessation
- 1990-01-26 NZ NZ243953A patent/NZ243953A/en unknown
- 1990-01-26 EP EP90903118A patent/EP0455726A1/en active Pending
- 1990-01-29 IE IE31890A patent/IE64234B1/en not_active IP Right Cessation
- 1990-01-29 PT PT92995A patent/PT92995B/pt not_active IP Right Cessation
- 1990-01-30 IL IL9321990A patent/IL93219A/en not_active IP Right Cessation
1991
- 1991-07-23 OA OA60047A patent/OA09509A/en unknown
- 1991-07-30 FI FI913625A patent/FI913625A0/fi not_active Application Discontinuation
1996
- 1996-03-14 HK HK46196A patent/HK46196A/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
IL93219A (en)	1998-12-27
HU207229B (en)	1993-03-29
ATE89737T1 (de)	1993-06-15
OA09509A (en)	1992-11-15
KR0137361B1 (ko)	1998-04-25
HUT57607A (en)	1991-12-30
HK46196A (en)	1996-03-22
EP0455726A1 (en)	1991-11-13
DK0382381T3 (da)	1993-07-12
PT92995A (pt)	1990-07-31
AU5048890A (en)	1990-08-24
NZ243953A (en)	1997-06-24
CA2045605C (en)	1997-02-11
AU633054B2 (en)	1993-01-21
JPH0651640B2 (ja)	1994-07-06
DE69001686D1 (de)	1993-07-01
PT92995B (pt)	1995-12-29
US5178855A (en)	1993-01-12
EP0382381B1 (en)	1993-05-26
KR910700069A (ko)	1991-03-13
DE69001686T2 (de)	1993-09-02
MY105798A (en)	1995-01-30
IE900318L (en)	1990-07-30
WO1990008554A1 (en)	1990-08-09
IL93219A0 (en)	1990-11-05
IE64234B1 (en)	1995-07-26
CA2045605A1 (en)	1990-07-31
EP0382381A1 (en)	1990-08-16
ZA90600B (en)	1990-10-31
ES2055314T3 (es)	1994-08-16
JPH03504980A (ja)	1991-10-31

Publication	Publication Date	Title
PT911033E (pt)	2004-04-30	Utilizacao do interferao de consenso para a reducao dos efeitos secundarios do tratamento com interferoes na hepatite viral
FI103180B1 (fi)	1999-05-14	Flurbiprofeenia sisältävien lääkkeiden valmistus kipujen ja/tai tulehdusten torjumiseksi eläimissä ja ihmisissä
BG60253B1 (bg)	1994-03-24	Човешки тъканен плазминогенен активатор
EP0377520A3 (en)	1991-07-17	Use of nicotine for the manufacture of a kit for the treatment of conditions susceptible to said treatment
FI913625A0 (fi)	1991-07-30	Behandling av nedsatt funktion av leukocyter med gm-csf.
EP0317568A4 (en)	1990-05-14	Use of stimulation of granulocyte-macrophage colonies for obtaining a medicament for the treatment of bacterial diseases.
KR890001580A (ko)	1989-03-27	B형 간염 바이러스에 의해 유발되는 염증 질환을 치료하는 이중가닥 rna를 함유하는 약물
IT9041503A0 (it)	1990-01-19	Dispositivo per la cura chirurgica dell'ametropia
IE890580L (en)	1989-08-24	Therapeutic agent for the prevention of intraventricular hemorrhage in premature infants
DK148890D0 (da)	1990-06-19	Farmaceutisk praeparat
KR870010871A (ko)	1987-12-18	재조합 인체 알파 인터페론에 의한 기저세포 암종의 병소내적 치료방법
ATE56147T1 (de)	1990-09-15	T-pa enthaltende medizinische zubereitung und deren verwendung.
EP0397211A3 (en)	1991-04-10	Percutaneous administration of 3'-azide-3'-deoxythymidine
IT1246050B (it)	1994-11-07	Impiego dell'eptastigmina nella terapia dell'ictus cerebrale.
Zhang	1985	The clinical study of cefamandole nafate.

Legal Events

Date	Code	Title	Description
1996-03-04	FD	Application lapsed